H.C. Wainwright Reiterates Buy Rating on Rain Therapeutics (RAIN)

Go back to H.C. Wainwright Reiterates Buy Rating on Rain Therapeutics (RAIN)
(NASDAQ: RAIN) Delayed: 1.11 -0.07 (5.93%)
Previous Close $1.18    52 Week High
Open $1.19    52 Week Low
Day High $1.19    P/E N/A 
Day Low $1.10    EPS
Volume 314,574